medigraphic.com
ISSN 1995-9427 (Print)

2023, Number 1

Next >>

Invest Medicoquir 2023; 15 (1)

Análisis multivariado discriminante para la presencia de miocardiopatía cirrótica

Romero MJ, Rodríguez-Denis D, Suarez PA

Language: Spanish
References: 15
Page:
PDF size: 385.90 Kb.


ABSTRACT

Introduction. The interrelation of clinical factors and of the complementary exams in the patients with hepatic cirrhosis in a predictive bioestatistic model for the diagnostic suspicion of the cirrhotic miocardiopathy in the current moment it would be of great utility like possible clinical tool.
Objectives. To estimate a discriminant predictive biostatistical model for the presence of cirrhotic myocardiopathy in the patients with hepatic cirrhosis in the study sample using clinical variables and of the complementary exams.
Methods. It was carried out a design of transverse, analytic, observational study and a discriminant multivariable analysis was executed to predict the presence of cirrhotic myocardiopathy in a sample of 152 patients entered with diagnostic of hepatic cirrhosis, being selected the same ones according to inclusion approaches and for appearance order among the years 2013 and 2019. The information was picked up in a data base and processed by means of SPSS version 20.0. The 2 formed groups (with presence or not of cirrhotic miocardiopathy) they were statistically comparable, that which allowed to carry out a Discriminant Multivariable Analysis leaning on in the independent variables: clinical and of the selected complementary exams, by means of which
Results. It was possible to estimate a classification function with a total discriminatory adjustment for the included patients of 90,8 % in probabilistic terms.
Conclusions. The cirrhotic miocardiopathy can be suspected using a predictive model of classification whose discriminant function can constitute a new clinic tools to the patient's head with hepatic cirrhosis.


REFERENCES

  1. República de Cuba. Ministerio de Salud Pública. Anuario estadístico de salud 2015 [Libro en Internet]. La Habana: Dirección Nacional de Registros Médicos y Estadísticas de Salud; abril 2016. Disponible en: http://www.sld.cu/sitios/dne/

  2. Kowalski HJ, Abelmann WH. The cardiac output at rest in Laennecs cirrhosis. Clin Invest 1953; 32:1025–33.

  3. Llach J, Ginés P, Arroyo V, et al. Prognostic value of arterial pressure endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology 2018;94:482–7.

  4. Moller S, Wiinberg N, Henriksen JH. Noninvasive 24-hour ambulatory arterial blood pressure monitoring in cirrhosis. Hepatology 2017; 22:88–95.

  5. Moller S, Henriksen JH. Cirrhotic cardiomyopathy. J Hepatol. 2018; 53:179-90.

  6. Salerno F, Gerbes A, Ginès P, Wong F, Arroyo V. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut. 2018; 56:1310-8.

  7. Ruiz-del-Arbol L, Monescillo A, Arocena C, Valer P, Gines P, Moreira V, et al. Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology. 2018; 42:439-47.

  8. Ruiz-del-Árbol L, Urman J, Fernández J, Gonzalez M, Navasa M, Monescillo A, et al. Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology. 2016; 38:1210-8.

  9. Castellanos Fernández M, Rogel Marroquín BI, RodriguezMaturell F, Arjona RodriguezIA,Lazo del Vallín S. Disfunción cardíaca en la cirrosis hepática.Rev Cubana Med.2017;53(2): 23-29.

  10. Fernández-Rodriguez CM, Prieto J, Zozaya JM. Arteriovenous shunting, hemodynamic changes, and renal sodium retention liver cirrhosis. Gastroenterology 2018; 104:1139–45.

  11. Levy M, Maher E, Wexler MJ. Euvolemic cirrhotic dogs in sodium balance maintain normal systemic hemodynamics. Can J PhysiolPharmacol 2018; 66:80–3.

  12. Henriksen JH, Møller S, Ring-Larsen H, et al. The sympathetic nervous system in liver disease. J Hepatol 2016; 29:328–41.

  13. Gadano A. Miocardiopatia cirrótica. IV Curso completo de hepatología. 6-7 de abril 2012. Buenos Aires. Argentina. Disponible en: www.sage.org.ar/download/hepato.pdf.

  14. del Árbol Olmos LR, Rodríguez Gandía MA. Disfunción cardiaca y enfermedad hepática. Progresos en Hepatología. Febrero 2007. Madrid. Disponible en: http://www.hepatoinfo.com/progresoshepatologia.php?f=200702[Consultado el 8 Agosto 2019].

  15. Herve P, Le Pavec J, Sztrymf B, Decante B, Savale L, Sitbon O. Pulmonary vascular abnormalities in cirrhosis. Best Pract Res ClinGastroenterol. 2018; 21:141-59.




2020     |     www.medigraphic.com